Skip to main content

Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment

  • Chapter
  • First Online:

Part of the book series: Advances in Experimental Medicine and Biology ((CBTMED,volume 1341))

Abstract

Colorectal cancer is the third most common form of cancer worldwide leading to escalating mortality rates and mainly includes hereditary, sporadic and colitis-associated cancer development. The escalated mortality rates is due to the limited treatment options as this form of cancer is usually not easy to diagnose in its early stages and are highly invasive leading to rapid metastasis of the malignant cells to the neighbouring tissue. In order to combat this limitation several chemotherapeutic regimens are now being combined with targeted therapies after the knowledge acquired on the inevitable effects of the tumor microenvironment on the colon cancer growth and progress. The colon tumor niche mainly consists of a large mass of tumor cells along with various immune cells, inflammatory cells, tumor macrophages and fibroblasts that infiltrate the tumor as it is a site of predominant inflammation. Among cells of the microenvironment, mesenchymal stem cells (MSCs) exhibiting ability to evolve into cancer associated fibroblasts (CAFs) have recently generated a major interest in the field. The physiological state of the tumor microenvironment is closely connected to discrete steps of tumorigenesis. The colon cancer cells elicit various factors with their direct interaction with MSCs or via paracrine fashion, which modulate these cells to promote cancer instead of performing their innate function of abating cancer progression. This review intends to highlight the necessity to exploit the cellular landscape of tumor microenvironment of colon cancer and a detailed understanding of the interactions between tumor epithelial cells and their stromal/inflammatory elements will aid in future perspectives for designing therapeutic regimens targeting tumor microenvironment to improve the clinical outcome of colon cancer.

Keywords

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
EUR   29.95
Price includes VAT (France)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
EUR   93.08
Price includes VAT (France)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR   116.04
Price includes VAT (France)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
EUR   158.24
Price includes VAT (France)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Abbreviations

CAFs:

Cancer Associated, Fibroblasts

CC:

Colon Cancer

CRC:

Colo Rectal Carcinoma

ECM:

Extracellular Matrix

EGF:

Epidermal Growth Factor

EMT:

Epithelial to Mesenchymal Transition

FAP:

Fibroblast Activating Protein

HGF:

Hepatocyte Growth Factor

MDSC:

Myeloid Derived Suppressor Cells

MIF:

Migration Inhibitory Factor.

MMP:

Matrix Metalo Proteinases

MSCs:

Mesenchymal Stem Cells

RANTES:

Regulated on activation, Normal T-cell Expressed and Secreted

SCF:

Stem Cell Factor

TAMs:

Tumour Associated Macrophages

TME:

Tumour Microenvironment

TNF:

Tumour Necrosis Factor

VEGF:

Vascular Endothelial Growth Factor

References

  • Ali S, Suresh R, Banerjee S et al (2015a) Contribution of microRNAs in understanding the pancreatic tumor microenvironment involving cancer associated stellate and fibroblast cells. Am J Cancer Res 5(3):1251

    PubMed  PubMed Central  Google Scholar 

  • Ali S, Dubaybo H, Brand RE, Sarkar FH (2015b) Differential expression of microRNAs in tissues and plasma co-exists as a biomarker for pancreatic cancer. J Cancer Sci Ther 7(11):336

    Article  CAS  Google Scholar 

  • Bahrami A, Khazaei M, Hassanian SM et al (2018) Targeting the tumor microenvironment as a potential therapeutic approach in colorectal cancer: rational and progress. J Cell Physiol 233(4):2928–2936

    Article  CAS  Google Scholar 

  • Balkwill FR, Capasso M, Hagemann T (2012) The tumor microenvironment at a glance. J Cell Sci 125(Pt 23):5591–5596

    Article  CAS  Google Scholar 

  • Bullock MD, Pickard KM, Nielsen BS et al (2013) Pleiotropic actions of miR-21 highlights the critical role of deregulated stromal microRNAs during colorectal cancer progression. Cell Death Dis 4(6):e684

    Article  CAS  Google Scholar 

  • Chen S, Huang EH (2014) The colon cancer stem cell microenvironment holds keys to future cancer therapy. J Gastrointest Surg 18(5):1040–1048

    Article  Google Scholar 

  • Chen J, Li C, Chen L (2015) The role of microvesicles derived from mesenchymal stem cells in lung diseases. Biomed Res Int 2015:985814

    PubMed  PubMed Central  Google Scholar 

  • Colangelo T, Polcaro G, Muccillo L et al (2017) Friend or foe?: The tumour microenvironment dilemma in colorectal cancer. Biochim Biophys Acta Rev Cancer 1867(1):1–8

    Article  CAS  Google Scholar 

  • David H (1988) Rudolf Virchow and modern aspects of tumor pathology. Pathol Res Pract 183(3):356–364

    Article  CAS  Google Scholar 

  • Dong W, Li H, Zhang Y, Yang H, Guo M, Li L, Liu T (2011) Matrix metalloproteinase 2 promotes cell growth and invasion in colorectal cancer. Acta Biochim Biophys Sin 43(11):840–848

    Article  CAS  Google Scholar 

  • Gout S, Huot J (2008) Role of cancer microenvironment in metastasis: focus on colon cancer. Cancer Microenviron 1(1):69–83

    Article  Google Scholar 

  • Heslin MJ, Yan J, Johnson MR, Weiss H, Diasio RB, Urist MM (2001) Role of matrix metalloproteinases in colorectal carcinogenesis. Ann Surg 233(6):786

    Article  CAS  Google Scholar 

  • Ibrahim AF, Weirauch U, Thomas M, Grünweller A, Hartmann RK, Aigner A (2011) MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 71(15):5214–5224. https://doi.org/10.1158/0008-5472.CAN-10-4645

    Article  CAS  PubMed  Google Scholar 

  • Illemann M, Bird N, Majeed A et al (2006) MMP-9 is differentially expressed in primary human colorectal adenocarcinomas and their metastases. Mol Cancer Res 4(5):293–302

    Article  CAS  Google Scholar 

  • Inoue T, Iinuma H, Ogawa E, Inaba T, Fukushima R (2012) Clinicopathological and prognostic significance of microRNA-107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol Rep 27(6):1759–1764

    PubMed  Google Scholar 

  • Jiang X, Hu S, Liu Q, Qian C, Liu Z, Luo D (2017) Exosomal microRNA remodels the tumor microenvironment. PeerJ 5:e4196

    Article  Google Scholar 

  • Kuninty PR, Schnittert J, Storm G, Prakash J (2016) MicroRNA targeting to modulate tumor microenvironment. Front Oncol 6:3

    Article  Google Scholar 

  • Landskron G, De la Fuente M, Thuwajit P, Thuwajit C, Hermoso MA (2014) Chronic inflammation and cytokines in the tumor microenvironment. J Immunol Res 2014:1–19

    Article  Google Scholar 

  • Lazennec G, Lam PY (2016) Recent discoveries concerning the tumor-mesenchymal stem cell interactions. Biochim Biophys Acta Rev Cancer 1866(2):290–299

    Article  Google Scholar 

  • Lu J, Getz G, Miska EA et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834

    Article  CAS  Google Scholar 

  • Melzer C, Yang Y, Hass R (2016) Interaction of MSC with tumor cells. Cell Commun Signal 14(1):20

    Article  Google Scholar 

  • Mohammadi A, Mansoori B, Baradaran B (2016) The role of microRNAs in colorectal cancer. Biomed Pharmacother 84:705–713

    Article  CAS  Google Scholar 

  • O’Malley G, Heijltjes M, Houston AM et al (2016) Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response? Oncotarget 7(37):60752

    Article  Google Scholar 

  • Peddareddigari VG, Wang D, DuBois RN (2010) The tumor microenvironment in colorectal carcinogenesis. Cancer Microenviron 3(1):149–166

    Article  CAS  Google Scholar 

  • Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19(11):1423–1437

    Article  CAS  Google Scholar 

  • Rhee KJ, Lee J, Eom Y (2015) Mesenchymal stem cell-mediated effects of tumor support or suppression. Int J Mol Sci 16(12):30015–30033

    Article  CAS  Google Scholar 

  • Ribatti D, Mangialardi G, Vacca A (2006) Stephen Paget and the ‘seed and soil’theory of metastatic dissemination. Clin Exp Med 6(4):145–149

    Article  CAS  Google Scholar 

  • Sansom SE, Nuovo GJ, Martin MM, Kotha SR, Parinandi NL, Elton TS (2010) miR-802 regulates human angiotensin II type 1 receptor expression in intestinal epithelial C2BBe1 cells. Am J Physiol Gastrointest Liver Physiol 299(3):G632–G642

    Article  CAS  Google Scholar 

  • Schee K, Fodstad Ø, Flatmark K (2010) MicroRNAs as biomarkers in colorectal cancer. Am J Pathol 177(4):1592–1599

    Article  CAS  Google Scholar 

  • Strubberg AM, Madison BB (2017) MicroRNAs in the etiology of colorectal cancer: pathways and clinical implications. Dis Model Mech 10(3):197–214

    Article  CAS  Google Scholar 

  • Tauriello DV, Batlle E (2016) Targeting the microenvironment in advanced colorectal cancer. Trends Cancer 2(9):495–494

    Article  Google Scholar 

  • Wang B, Shen ZL, Gao ZD, Zhao G, Wang CY, Yang Y, Zhang JZ, Yan YC, Shen C, Jiang KW, Ye YJ (2015) MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP 4K4/c-Jun/MDM2 signaling pathway. Cell Cycle 14(7):1046–1058

    Article  CAS  Google Scholar 

  • Wang M, Zhao J, Zhang L et al (2017) Role of tumor microenvironment in tumorigenesis. J Cancer 8(5):761

    Article  CAS  Google Scholar 

  • Xu K, Chen Z, Qin C, Song X (2014) miR-7 inhibits colorectal cancer cell proliferation and induces apoptosis by targeting XRCC2. Onco Targets Ther 7:325

    Article  Google Scholar 

  • Zhang H, Li M, Han Y, Hong L, Gong T, Sun L, Zheng X (2010) Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig Dis Sci 55(9):2545–2551

    Article  CAS  Google Scholar 

  • Zhang Y, Guo L, Li Y, Feng GH, Teng F, Li W, Zhou Q (2018) MicroRNA-494 promotes cancer progression and targets adenomatous polyposis coli in colorectal cancer. Mol Cancer 17(1):1

    Article  Google Scholar 

  • Zucker S, Vacirca J (2004) Role of matrix metalloproteinases (MMPs) in colorectal cancer. Cancer Metastasis Rev 23(1–2):101–117

    Article  CAS  Google Scholar 

Download references

Acknowledgement

The authors are thankful to Chettinad Academy of Research and Education for providing the infrastructural support and to SERB, DST, Govt. of India for providing the financial support. The authors are thankful to Mr. Jaganth Arunachalam for technical help in formulating the table.

Funding

This work was supported fully by the grants sanctioned to Dr. Antara Banerjee (PI) from the SERB-DST Govt. of India with the sanction file no ECR/2017/001066.

Disclosure of Interest

The authors report no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antara Banerjee .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Banerjee, A. et al. (2019). Role of Tumor Specific niche in Colon Cancer Progression and Emerging Therapies by Targeting Tumor Microenvironment. In: Turksen, K. (eds) Cell Biology and Translational Medicine, Volume 13. Advances in Experimental Medicine and Biology(), vol 1341. Springer, Cham. https://doi.org/10.1007/5584_2019_355

Download citation

Publish with us

Policies and ethics